Ismigen

Ismigen Uses, Dosage, Side Effects, Food Interaction and all others data.

Each sublingual tablet contains 50 mg Ismigen. Of this, 7mg corresponds to- Staphylococcus aureus 6 billions Streptococcus pyogenes 6 billions Streptococcus viridans 6 billions Klebsiella pneumoniae 6 billions Klebsiella ozaenae 6 billions Haemophilus influenzae B 6 billions Neisseria (Moraxella) catarrhalis 6 billions Streptococcus (Diplococcus) pneumoniae 6 billions (1 billion unit of type TY1/EQ11; 1 billion unit of type TY2/EQ22; 1 billion unit of type TY3/EQ14; 1 billion unit of type TY5/EQ15; 1 billion unit of type TY8/EQ23; 1 billion unit of type TY47/EQ24) and 43mg Glycine for the lyophilization process.

Ismigen
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Ismigen
Generic	Lyophilized Bacterial Lysate
Weight	7mg
Type	Tablet, Sublingual Tablet
Therapeutic Class	Other antibacterial preparation
Manufacturer	Lupin, Unimed Unihealth
Available Country	India, Bangladesh
Last Updated:	September 19, 2023 at 7:00 am

Uses

Prevention of acute, sub-acute, chronic or recurrent infections of the upper respiratory tract (Common cold, Sinusitis, Pharyngitis, Epiglottitis, Laryngotracheitis, Otitis) and lower respiratory tract (Bronchitis, Bronchiolitis, Pneumonia, Acute Exacerbations in Chronic Obstructive Pulmonary Disease).

Dosage

Ismigen dosage

Children 3 years and above, adults and elderly: One sublingual tablet daily, to be dissolved under the tongue before meal for 10 consecutive days per month, for three consecutive months.

Side Effects

In rare cases, respiratory, thoracic and mediastinal violations; skin and subcutaneous violations; general disorders, digestive disorders and local sublingual disturbances caused by the drug. In any case of violation, the treatment should be discontinued.

Interaction

Interactions with other drugs is not known.

Pregnancy & Breastfeeding use

Although toxic effects were observed in animals, not controlled studies were performed in pregnant women. For that reason, it is recommended to avoid the use during the first three months of confirmed or suspected pregnancy. During the period of fertility and lactation, special observations on the effect of the drug was carried out.